Forward Pharma Operations ApS: Financial statements 2018
CVR: 38757504
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Forward Pharma Operations ApS (CVR 38757504) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 105,339 and a net result of DKK -15,791,179. The profit margin was -14,990.8%. Equity in the 2018 report amounted to DKK 332,247,967. The solvency ratio was 91.2%.
- Revenue
- DKK 105,339
- Gross Profit
- DKK -27,059,514
- Profit/Loss
- DKK -15,791,179
- Equity
- DKK 332,247,967
- Total Assets
- DKK 364,402,785
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Forward Pharma Operations ApS has published its interim report for the period June 30, 2017 – December 31, 2017.
About Forward Pharma Operations ApS
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 30 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity in the 2024 report amounted to DKK 280,041,147.